Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has updated key personnel and institutional affiliations, replacing Daniel Laheru, MD from Johns Hopkins University with Lei Zheng, MD from The University of Texas Health Science Center San Antonio. Additionally, some dates have been modified, indicating a shift in scheduling.
    Difference
    1%
    Check dated 2025-05-08T05:20:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T03:13:04.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on resectable pancreatic ductal adenocarcinoma (PDAC), while adding new identifiers and collaborators.
    Difference
    26%
    Check dated 2025-04-16T14:23:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new study led by the University of Texas Health Science Center at San Antonio, with a revised timeline and additional locations, while removing references to a previous study at Johns Hopkins University.
    Difference
    8%
    Check dated 2025-04-09T09:15:39.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T21:05:29.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:54:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.